1002. Deputy Colm Burke asked the Minister for Health to provide an update on the ongoing independent review by the Health Products Regulatory Authority on the method of sale and supply of codeine containing medicinal products that are currently available without prescription; and if she will make a statement on the matter. [69678/25]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Medicinal Products.
1,228 questions match, newest first.
1004. Deputy Colm Burke asked the Minister for Health in the event of the Health Products Regulatory Authority makes recommendations which provide that codeine containing medicinal products can only be made available through prescription, the mechanisms that will be put in place to assist those who are reliant on these products and who have been able to purchase them without prescription; and if she will make a state…
1005. Deputy Colm Burke asked the Minister for Health if the review being carried out by the Health Products Regulatory Authority on the method of sale and supply of codeine containing medicinal products are prepared to consider putting in place additional safeguards through pharmacies without the requirement for prescription; and if she will make a statement on the matter. [69681/25]
1047. Deputy Eoghan Kenny asked the Minister for Health if the refusal of an injection for a person (detailed supplied) will be reviewed by the health service; if the reason for the refusal will be outlined; and if she will make a statement on the matter. [70002/25]
1057. Deputy Ruth Coppinger asked the Minister for Health in light of the recent updated statement by the World Health Organisation on the necessity and cost of medication that treats obesity, if she will consider the inclusion of weight loss injections in the drug payment scheme for all those who suffer from obesity. [70174/25]
1059. Deputy Duncan Smith asked the Minister for Health when a decision will be made under the full health technology commissioned by the HSE in respect of the medicine daridoxerant (quviviq); if this will be expedited; and if she will make a statement on the matter. [70202/25]
1078. Deputy Ivana Bacik asked the Minister for Health her views on the granting of access to dupilumab for the treatment of eosinophilic oesophagitis in children up to 12; her engagement with the HSE and advocacy groups in respect of same; and if she will make a statement on the matter. [70235/25]
1083. Deputy Emer Currie asked the Minister for Health if a medication is being considered for the drug payment scheme (details supplied); and if she will make a statement on the matter. [70327/25]
542. Deputy Barry Ward asked the Minister for Health her views on the merits of establishing a priority for the acquisition of EU made pharmaceuticals; and if she will make a statement on the matter. [68985/25]
543. Deputy Barry Ward asked the Minister for Health to detail any research carried out by her Department into ending the acquisition of Israeli made pharmaceuticals; and if she will make a statement on the matter. [68986/25]
237. Deputy Paul Murphy asked the Minister for Health if her attention has been drawn to a charge being placed on blister packs; and if she will instruct her Department to investigate the matter and reverse the decision. [68189/25]
247. Deputy Richard Boyd Barrett asked the Minister for Health her plans to reinstate funding for pharmacy blister packs (details supplied). [68230/25]
254. Deputy Naoise Ó Muirí asked the Minister for Health the progress of licensing the drug luthera, which is required for the treatment of grade 4 neuroendocrine cancer; the expected timeline for approval; and if she will make a statement on the matter. [68274/25]
261. Deputy Michael Cahill asked the Minister for Health if she will liaise with the HSE and representatives of pharmacies to develop a system where patients, especially older patients can avail, free of charge of their prescriptions by way of blister packs, for ease and safety of medication administration; and if she will make a statement on the matter. [68363/25]
264. Deputy Michael Healy-Rae asked the Minister for Health the reason a contract change between community pharmacies and the HSE will see the price of blister packs increase by 200% from 1 January 2026; and if she will make a statement on the matter. [68386/25]
265. Deputy Pearse Doherty asked the Minister for Health if she is aware of pharmacy charges medical card holders pay for medication dispensed in blister packs; the impact the charges have on those on low incomes; and if she will make a statement on the matter. [68403/25]
593. Deputy Conor Sheehan asked the Minister for Health the number of persons prescribed the weight loss drug ozempic, by county from 2023 to date in 2025, in tabular form. [67730/25]
594. Deputy Conor Sheehan asked the Minister for Health the number of persons prescribed the weight loss drug mounjaro, by county, from 2023 to date in 2025, in tabular form. [67731/25]
632. Deputy Claire Kerrane asked the Minister for Health if a drug (details supplied) can be made available under the HSE drugs scheme given the very high monthly cost of €7,600 which is out of reach, given this drug provides lifesaving treatment; and if she will make a statement on the matter. [67985/25]
633. Deputy Aengus Ó Snodaigh asked the Minister for Health the reason for the continued failure to approve and purchase the drug selpercatinib as a targeted treatment for medullary thyroid cancer and small cell lung cancer for patients in Ireland; the number of patients undergoing treatment for these forms of cancer who would benefit from such treatment; the cost of providing it; if she will ensure the approval and …
503. Deputy Colm Burke asked the Minister for Health the actions that have been taken to date to meet the Programme for Government commitment to investigate early access schemes for certain types of medicines; whether there are plans to consult with patient organisations as part of this process; and if she will make a statement on the matter. [66868/25]
588. Deputy Gillian Toole asked the Minister for Health when a review of the rate of value added tax on oral vitamin and mineral supplements, currently 13.5% rate, will be carried out; and the reason there is a disparity in VAT classification between oral pharmaceuticals, and oral supplements for health promotion; and if she will make a statement on the matter. [67255/25]
323. Deputy Cathal Crowe asked the Minister for Health if a person (details supplied) in County Clare can get ozempic on their medical card or on the drugs refund scheme given it costs €160.00 per month; and if she will make a statement on the matter. [66550/25]
337. Deputy David Cullinane asked the Minister for Health if she will urgently review the decision to remove State reimbursement for blister pack medication services; if she is aware that this change will allow pharmacies to introduce private fees of up to €50 per person per month; if she will outline the measures the Department is taking to prevent adverse impacts on patients who rely on blister packs for medication…
353. Deputy John McGuinness asked the Minister for Health if she will review the prescribed allocation of glucose sensors (details supplied). [66660/25]